ABSTRACT: Due to the medicinal importance of triazole derivatives, the antimicrobial property of three synthesized triazole derivatives were screened in vitro against some Gram positive and Gram negative pathogenic bacteria and some pathogenic fungi. In this study, three compounds 2- The compounds showed moderate antimicrobial activity against all the tested organisms and the results are comparable to standard antibiotic kanamycin. The MIC values of the compounds were found to be in the range of 16~64µg/ml. The low MIC and MBC values and high sensitivity of pathogenic microorganisms to the compounds led to conclude that the triazole derivatives have potential antimicrobial properties.
INTRODUCTION
One of the main causes of morbidity and mortality in immunocompromised patients in the developing countries is mainly due to the frequent life threatening infective diseases originated from various pathogenic microorganisms. A large number of drugs have been discovered so far to combat such situation. But none of these drugs could completely destroy such microorganisms in some cases. It is mainly because these organisms are developing resistance towards such drugs. As a result, the drugs already in use are gradually losing their effectiveness. The discovery of novel antibiotics which are much more effective against such microorganisms is essential. The 1,2,4-triazoles and 
MATERIALS AND METHODS
The organisms used were collected from the Microbiology Laboratory of the Institute of Nutrition and Food Sciences, Dhaka University, Bangladesh. All chemicals used throughout the research were purchased from BDH (England) and used without further purification.
Preparation of inoculums. Suspension of organism was prepared as per McFarland nephelometer standard. A 24 hour old culture was used for the preparation of bacterial suspension. Suspension of organism was made in a sterile isotonic solution of sodium chloride (0.9% w/v) and the turbidity was adjusted so that it contained approximately 1.5 × 10 8 cells/ml. It was obtained by adjusting the optical density of the bacterial suspension to that of a solution of 0.05 ml of 1.175% of barium chloride and 9.95 ml of 1% sulphuric acid.
Antimicrobial screening. The synthesized compounds were screened in vitro for their antimicrobial activity against three gram-negative (Escherichi coli, Shigella shiga and S. sonnei) and three gram-positive (Bacillus megaterium, B. subtilis, and Sarcina lutea) bacterial strains using disc diffusion method. Briefly, three calculated amount (5 mg, 10 mg and 20 mg) of the compounds S 1 , S 2 and S 3 were dissolved in 1 ml of DMSO in three different vials for getting solutions having concentrations of 50 µg/disc, 100 µg/disc and 200 µg/disc respectively. They were then applied on filter paper disc. Standard kanamycin (30 µg/disc) was used as positive control and DMSO as negative control. Both experimental and control discs were placed in petridishes seeded with organism in nutrient agar medium. The petridishes were kept in a refrigerator at 4°C for 24 hours to ensure diffusion of the test materials. Finally, they were incubated at 37±1°C for 24 hours and all experiments were done as triplicates. The antibacterial activity was determined by measuring the diameter of zone of inhibition in mm.
Determination of MIC and MBC. The Minimum Inhibitory Concentration (MIC) and
Minimum Bactericidal Concentration (MBC) of S 1 , S 2 , and S 3 were determined by serial dilution technique against the above mentioned pathogenic bacteria. S 1 , S 2 and S 3 were used from a concentration of 1 µg/ml to 512 µg/ml. A control test-tube containing only medium (nutrient broth medium) was used to confirm the sterility of the medium. Bacterial suspension (10 µl) containing 10 7 cells/ml was inoculated into all tubes. All of the test tubes were incubated at 37±1°C and observed for bacterial growth for 24 hours for MIC and 96 hours (4 days) for MBC determinations After inoculation for 24 hours, the test tube with no visible growth of the microorganism was taken to represent the MIC value of the sample in µg/ml. MBC, in which no viable organism occurred was determined by keeping the test tubes which was used for MIC determination for four days. After four days, bacterial growth was observed and MBC was determined at lowest concentrations where no bacterial growth was observed.
Antifungal activity. For antifungal screening, each sample was tested at concentrations of 100, 200, 400 µg/disc. The experimental protocol was almost same as antibacterial screening except the plates were incubated at 37±1˚C for 48h and Nystatin disc was used as positive control. All experiments were done in triplicates.
Statistical analysis. The experimental results have been expressed as the mean ± SEM (Standard Error of Mean). Statistical analysis was performing with SPSS software of 10 versions.
RESULTS AND DISCUSSION
The results for the antibacterial activity of S 1 , S 2 , and S 3 as well as the Kanamycin have been presented in Table 1 . The compounds showed a significant antibacterial activity against all test organisms. The diameter of zone of inhibition of S 1 at the dose of 50 µg/disc against B.megaterium, B. subtilis, E. coli, S. lutea, S. shiga, and S. sonnei were found to be 18 ± 1.2, 19 ± 1.6, 20 ± 1.0, 17 ± 1.7, 20 ± 2.1 and 24 ± 2.5 mm, respectively. These results indicate that compound S 1 is more effective against Bacillus megaterium (24±2.5 mm) and all these values were quite comparable with those obtained with kanamycin at dose 30 µg/disc in Table 1 . The values of zone of inhibition for the compounds S 2 and S 3 at 50 µg/disc were also quite comparable with kanamycin at 30 µg/disc. Compound S 2 showed highest inhibition of growth of S. lutea and B. megaterium (20 ± 1.2 mm and 19 ± 1.0 mm respectively) whereas compound S 3 revealed highest activity against Shi. shiga (20 ± 3.6 mm). All these compounds showed higher zone of inhibition when tested with higher doses (Table 1) . The MIC values of S 1, S 2 , and S 3 were determined against early cited six pathogenic bacteria and the results are shown in Table 2 . The MIC values of S 1 were found to be between 16-32 µg/ml and the MBC values for S 1 were 32-128 µg/ml. On the other hand the MIC and MBC values of S 2 and S 3 were also found to be between 16-64 and 64-256 µg/ml in Table 2 . From the above results, it is said that there is evident that there is no concrete correlation between antimicrobial activity, MIC and MBC values.
Antifungal activity of the compounds were also determined at three different doses (100, 200, 400 µg/disc) against six pathogenic fungi such as Aspergillus flavus, A. fumigatus, A. niger, Candida albicans, Human-3 sp, and Vasinfctum sp. At lower doses all these organisms were almost insensitive to the fat compounds but at higher doses the compounds showed mild to moderate antifungal activity which are given in Table 3 . Compound S 1 showed highest activity against Aspergillus niger (zone of inhibition 16 ± 2.2 mm at 200 µg/disc) whereas S 2 and S 3 were effective to same extent against Human-3 sp. (zone of inhibition 09 ±1.3 mm at 100 µg/disc) and Vasinfctum sp. (zone of inhibition 08±1.7 mm at 100 µg/disc) respectively.
In the present study we observed almost similar antimicrobial characteristics of 2- 
